The facility has experienced significant expansion since its establishment in 2006
Conducted at at New Jersey facility
Four of nine evaluable patients responded to TILT-123 combined with pembrolizumab and pegylated liposomal doxorubicin, including two complete responses
StemFit Basic05 is a next-generation, animal origin-free medium designed for scalable hPSC manufacturing
Hyland Digital Pathology is an enterprise-grade digital pathology solution that ends the clinical, operational, and architectural fragmentation that has kept pathology disconnected from healthcare’s digital transformation
Sign in to your account